Trial Profile
Clinical study on ulinastatin and minocycline in control of cognitive dysfunction after coronary artery bypass grafting
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 03 Jan 2017
Price :
$35
*
At a glance
- Drugs Dexmedetomidine (Primary) ; Minocycline (Primary) ; Ulinastatin (Primary)
- Indications Cognition disorders
- Focus Pharmacodynamics
- 21 Aug 2013 New trial record